> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
> See specialized channels

  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter

BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization & Comparability Testing

| Print |
Monday, 23 September 2013 14:45 (UTC + 2)

BioOutsource Logo

Expands Glasgow, Scotland Testing Facilities and Ramps up Commercial Activities in US and Asia-Pacific  

BOSTON, Mass., US and GLASGOW, Scotland, UK, September 23, 2013 / B3C newswire / – BioOutsource Ltd. (“BioOutsource”), a leading international Contract Testing Organization (CTO) has consolidated its position as the leading expert in the biological analysis of Biosimilar Monoclonal Antibodies for the biopharmaceutical industry.  Strategic internal R&D investment has enabled the creation and launch of a wide range of off-the-shelf testing methodologies to support comparability, stability and lot release testing for Biosimilars.  As a result the company has achieved excellent market penetration and sales growth this year and is now working in collaboration with many of the world’s leading Biosimilar companies.

Our extensive experience in developing and validating cell-based assays and strategic R&D investment has created a niche position for us within the industry, which enables BioOutsource to provide testing solutions that can significantly reduce the time and cost of Biosimilar development programmes,” commented BioOutsource CEO Gerry MacKay. “We are continuing to invest and expand our testing capabilities in Glasgow, Scotland and are significantly increasing commercial activities in the North American and Asia-Pacific regions to support surging demand for Biosimilar characterisation & comparability testing.  We are delighted to be working with more than 30 of the top Biosimilar players globally, and look forward to continued strong growth in 2014.”  

About BioOutsource Ltd
BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of Biologics, Vaccines & Biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry’s increasingly preferred testing partner. We understand the importance of our service to support our client’s critical testing requirements and as a result, continually strive to provide a world class service globally.


Dr. Verna McErlane
Director of Sales
BioOutsource, Ltd.
+ 44 (0) 141 946 4222
This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Bill Douglass
Gotham Communications, LLC
This e-mail address is being protected from spambots. You need JavaScript enabled to view it